In the BioHarmony Drug Report Database
Deflazacort
Emflaza (deflazacort) is a small molecule pharmaceutical. Deflazacort was first approved as Emflaza on 2017-02-09. It is used to treat duchenne muscular dystrophy and inflammation in the USA.
Trade Name
|
Emflaza |
|---|---|
Common Name
|
deflazacort |
ChEMBL ID
|
CHEMBL1201891 |
Indication
|
duchenne muscular dystrophy, inflammation |
Drug Class
|
Image (chem structure or protein)